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Influenza and other acute respiratory infections (ARIs) contribute significantly 
to human morbidity and mortality globally. Animal experiments and human challenge 
studies have not provided an adequate explanation about the relative importance of 
social, behavioral and physical environment in the transmission of ARIs and are 
limited due to uncertainty about the generalizability of their findings to a natural 
infection. Also, household transmission studies seldom characterize all potential 
transmission covariates e.g. environmental conditions, leaving a gap in the knowledge 
of transmission mechanisms. Here, we describe the design and preliminary results of 
an extensive college dormitory ARI transmission study that has the potential to 
characterize several important ARI transmission covariates; we critically appraise the 
design and show how the findings from such design can be applied to answer most of 
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Chapter 1: Introduction 
Problem significance 
Despite huge efforts being expended towards the prevention and control of acute 
respiratory infections (ARIs), they still pose a significant burden on healthcare and 
the economy. ARIs such as common cold and pharyngitis, represent one of the 
biggest single contributors to the overall burden of disease in the world as measured 
by disability-adjusted-life-years (DALY) lost (1–3). The DALY for a disease or 
health condition is the sum of the years of life lost from premature mortality in the 
population and the years lost from disability in people living with the health condition 
or its consequences (4). Globally, about 4.5 million people die from ARIs yearly, and 
ARIs account for about 100 million hospitalizations leading to expenditure of 
millions of dollars (1,5). During yearly influenza epidemics in the United States, 
about 50,000 influenza-related deaths have occurred from 1976 to date. (6) 
Broadly, ARIs are caused by bacterial or viral pathogens. Bacterial pathogens are 
less-common causes of ARIs but can include Streptococcus pneumonia, Mycoplasma 
pneumonia, Haemophilus influenza, Chlamydophila pneumonia, Coxiella 
burnetii and Legionella pneumophila especially in immunocompromised individuals 
(7). Viral causative agents of ARIs include rhinoviruses, respiratory syncytial virus, 
influenza virus, parainfluenza virus, human metapneumovirus, adenovirus, and 
coronaviruses (8). Though most viral ARIs are self-limiting, very large studies (9,10) 
have shown that they even contribute more than other infectious agents to the 




spread very rapidly within communities across the globe. For example, the World 
Health Organization (WHO) reports that every year, influenza virus causes 
respiratory tract infections in 5–15% of the population and severe illness in 3–5 
million people leading to between 290,000 and 650,000 deaths (11,12). In 2003, 
severe acute respiratory syndrome (SARS), a novel strain of coronavirus spread very 
rapidly throughout the world leading to thousands of deaths (13). Also, respiratory 
infections due to viral pathogens may predispose to more serious respiratory 
complications such as bacterial sinusitis, bronchitis, or pneumonia. The 2017 – 2018 
influenza season was characterized predominantly by the circulation of the influenza 
A (H3N2) virus which has been observed to cause more severe illnesses than H1N1 
and Influenza B viruses (14). Expectedly, hospitalization rates in the last season were 
high and so was the number of mortalities recorded especially for children and the 
elderly. Though similarities abound between the clinical syndromes of various 
respiratory viruses, they may possess differing transmission patterns. Understanding 
the predominant mode or modes of transmission of each of these infectious agents 
from person-to-person is crucial to the understanding of how they behave in 
environments and the impact that various social, physical and behavioral 
environmental factors have on their transmissibility. All these put together will 






Chapter 2: Literature Review 
Relevant theory 
In the scientific world, there is no consensus about the modes of transmission of these 
individual viral agents. Pica et al  (15) provided a classification for modes of 
transmission of ARIs which defines contact transmission as direct and indirect while 
airborne comprises both droplet spray and aerosol modes. Contact transmission (both 
direct or indirect) arises from contact with pathogen-containing droplets: direct 
contact transmission refers to physical contact and transfer of pathogens from an 
infected person to a susceptible person, but indirect contact transmission refers to 
contact with fomites and subsequent transport of the pathogen via, for example, hands 
to the upper respiratory tract (16). When large droplets are generated by coughing and 
sneezing, they can get deposited immediately onto the mucous membrane of 
susceptible people, this is known as droplet transmission (16). These large droplets 
gravitationally settle quickly hence droplet transmission constitutes a transmission 
mode that is mainly significant for close contacts (16). Airborne transmission occurs 
via inhalation of very small respiratory droplets (aerosols)  that are small enough to 
remain airborne (17).  
Since the first major influenza outbreak - the “Spanish Flu” of 1918 which led to the 
death of about 50 million people worldwide, scientists have been investigating the 
modes of transmission of ARIs. While great discoveries have been made, there are 




strategies and ever since then, different methods of study have been designed to try to 
answer the lingering questions.  
Experimental infection of animals or healthy volunteers has been an important 
method of studying ARIs for several reasons including that they provide unique 
opportunities to describe the progressive course of the illness from the onset as well 
as the shedding and symptoms characteristics prospectively. They also offer a 
controlled environment making it easier to study the impacts of environmental factors 
on transmission. Perhaps because of these, many early studies on influenza were 
experimentally done on animals and humans with the aim of observing the effects of 
various conditions on the transmission (18,19) . In an early human experimental study 
following the 1918 pandemic, upper respiratory secretions from infected humans that 
were collected during the pandemic in the active phase of their infections were 
inoculated into the nostrils of a group of sailors who were onboard during the 
outbreak and who were thought to have had no prior exposure to the virus. In the 
same study, blood samples from infected influenza patients were subcutaneously 
injected onto another group of sailors. In both experiments, no evidence of disease 
was observed in the subjects. The results from these experiments brought to the front, 
important questions about the transmission of the deadly virus, questions such as, 
“What is the point of entry of the virus? “What is the mode of transmission and when 
is the most infectious time in the clinical course of the disease?” Subsequent studies, 
including experimental studies, helped to shed more light on some of these queries. 
Careful intranasal liquid inoculation of the viral particles and in some cases, aerosol 




non-human primates. (20–24) However, there remains the concern that the spectrum 
of disease observed with artificial infections and transmission pattern and infections’ 
loci may differ from that in natural infections thus limiting the external validity of 
these studies. Nevertheless, these studies have gone to show the importance of 
different modes of infection in transmission, but up to date, the relative importance of 
each of them is still unclear for different pathogens. The reasons for these varieties 
could include the differences in the virion structures of the viruses influencing the 
pervasiveness of the particles, the immunogenicity of the viruses, the clinical 
syndromes such as the quantity of nasal secretions in the infected people 
(15,25). RSV and Adenovirus, for example, have been suggested to be primarily 
spread by contact (direct and indirect) transmissions (15). In one study by Hall et al 
(26), where 3 categories of subjects were made to come in contact with a highly 
symptomatic infant with heavy secretions, one category of subjects played with the 
infant, changed the child’s diapers, another category touched the infant’ environment 
but not the infant while a third category sat next to the infant for 3 hours without 
making any contact. Five of the 7 who cuddled the infant, 4 of 10 who touched and 
none of 14 who sat developed RSV infection. Possible explanations for the striking 
findings are that infants with RSV excrete a significant number of viral particles in 
their nasal secretions for days and RSV is now known to survive well on 
impermeable surfaces, skin, and gloves, for many hours thus providing opportunities 
to contaminate hands. In another study, researchers detected viable infectious 
particles of RSV on impactors placed 1m and 5m from some infected children’s cots 




RSV could be transmitted via aerosols (27). Similarly, varied transmission patterns 
and modes have been observed for Adenovirus and Coronavirus respiratory infections 
(28–30).  
To further investigate transmission dynamics, studies have been conducted in 
households or families and communities because a significant number of ARI 
transmission occur within these environments during epidemics (31) with the 
rationale that the improved knowledge of the transmission dynamics of each ARI 
within families and in the community will accelerate the development of effective 
control strategies to reduce its burden. Hence, households studies have increasingly 
gained attention. (32). In these studies, households are recruited prospectively from a 
sampling frame that includes the whole community, then participants are followed up 
prospectively to identify infections and illnesses. Household contacts of ill 
participants are then followed up as well to identify secondary illnesses. Several 
follow-up studies of families during one or several consecutive influenza seasons 
have described the occurrence and spread of infections in households in relation to 
age, family composition, crowding, circulating viral strains, exposure in the 
community, and prior immunity. During the 2009 influenza pandemic, household 
studies were used to provide early estimates of transmission dynamics of the novel 
viral strain H1N1 in confined settings (33–35). Household contacts are easy to 
identify and follow up and they provide a well-defined number of susceptible or 
exposed people. They have also provided a means to evaluate intervention strategies 
such as anti-viral medications and vaccination (36–38) and facemasks and hand 




dynamics has been provided including “serial intervals”, “secondary attack rates” or 
“secondary infection risks” (32,34–37,40–43), all of which are important when 
designing mechanistic models for infectious diseases and are important when 
predicting characteristics of epidemics. The serial interval is the time from the onset 
of illness in the index case to the time of onset of illness in the secondary cases while 
the secondary infection risk is the number of secondary cases divided by the number 
of exposed contacts (31). Household studies are limited, however, one for the huge 
amount of resources and logistics required to conduct them, also because it is difficult 
to estimate the total number of secondary infections due to one index case since some 
transmissions occur outside the household settings. In addition, in typical household 
studies, index cases are recruited after presenting with illnesses and as such 
recruitment may be selective for serious-illness-causing infections. If less serious 
illnesses are associated with greater transmissibility, then household studies are likely 
to underestimate transmissibility.  
Other studies have been conducted in “total institutions”. A total institution is a place 
of work or residence where many people who are similarly situated are cut off from 
the larger community for a significant time and together lead an enclosed life and 
make frequent contacts (44). Examples of such include military barracks, ships, 
hospitals, nursing homes, and college dormitories. Outbreaks have been reported to 
be particularly high in such institutions and epidemiological investigations are often 
carried out there (45–47). Also, outbreaks have been particularly worrisome in 
schools and dormitory environments where close and crowded living conditions and 




because they provide unique opportunities for infections to be transmitted and studied 
thus offering a classic example of how social networks can affect the transmission of 
infectious disease since the role of social network in transmissibility has been 
identified and emphasized (49–53). Also, total institutions have been valuable in the 
evaluation of intervention strategies such as vaccination, isolation, quarantine, and 
assessment of their potential usefulness in curbing transmission (50,54).  
Study aims 
 
A novel study conducted in residence halls at the University of Maryland in the 
Spring of 2017 is described here. The study offers a wealth of data to examine 
biological and social markers of susceptibility to infection and contagiousness among 
community-acquired cases and their closest contacts on campus.  The dormitory 
environment provides a unique and powerful setting in which to investigate 
transmission and contagiousness because it represents a microcosm of greater social 
communities while facilitating observation of tight-knit social networks. Focus on a 
living-learning community with a concentration on health not only means that the 
population under study includes numerous close social network connections because 
of shared courses, dorm space, and social activity, but also the possibility that health-
minded students may be more interested in the research and sets the groundwork for a 
more community-based participatory model that might facilitate high participation 
levels and quick reporting of illnesses and close contacts. Furthermore, the dormitory 
environment under study provides findings interpretable to the military barrack and 




study. We also describe the cohort, their infections, and some preliminary data about 
their connectivity. Finally, we will critically appraise the college dorm study and 









Chapter 3: Methods 
We performed a prospective study to identify and examine the transmission of 
influenza and other acute respiratory infections within a selected cohort of college 
dormitory students. 
Overall study group eligibility 
The target study group comprised students of University of Maryland at least 18 years 
of age who were in their first year and lived on certain floors in one of the dormitories 
assigned to a university living-learning program. The university living-learning 
program is a selective program that brings together scholarly students with a common 
academic interest to a specialized residential community, providing for them 
curricular and co-curricular activities that are specially designed for them. Students in 
this community take a series of courses together during their first two years in the 
university, participate in field trips and social events as members of the community, 
and the majority live together in a single dormitory.  
For ease of surveillance, we limited participation-eligibility, to students in one of the 
living-learning programs. Most of the students in that program lived on 3 floors on 
one wing of the dormitory, but to promote equity and capture relevant social 
networks, those not in the living-learning program but who lived on any of those 
three floors were eligible to participate in the study. The overall cohort was thus 
divided into main and peripheral cohorts. Total number of eligible and enrolled 





Table 1. Target group showing the divisions of the students in the overall cohort. 
Location of Residence 
 Target Floors Other Total 
 Eligible (N) Enrolled 
N (%) 










43 (68%) Main Cohort 
(15) 
6 (40%) 97 48 (49.5%) 
LLC student without 






of an LLC student 
Main Cohort 
(26) 
7 (26.9%) Peripheral 
Cohort (1) 
- 27 13 (48%) 
Other students on 
targeted floor  
Main Cohort 
(22) 
7 (31.8%) - - 22 7 (31.8%) 
Total 111 57 (51.4%) 35 11 
(31.4%) 
146 68 (46.6%) 
Abbreviation: LLC = Living Learning Community 
This table describes the target group of students and their divisions within the overall cohort. Main cohort 
indicated by orange colored cells and the peripheral cohort indicated by grey colored cells. Students in the main 
cohort could be evaluated as self-reported cases or contacts while those in the peripheral cohort could only be 
evaluated as contacts. 
 
The size of the overall eligible study cohort was 146. There were 97 students in the 
scholars’ program and 49 others who were either their roommates or resided on the 
same floors as them. 
Study branches, specific branch eligibility, and recruitment 
Students in the main cohort were eligible to be evaluated as either self-reported cases 





 We obtained a list of all eligible participants, their room numbers, and their 
institutional e-mail addresses from the University Registrar. We sent emails leading 
up to the beginning of the study to inform them about the study purposes and 
procedures. A unique URL address was emailed to each eligible participant to invite 
them to enroll in the study and to get them to provide baseline information and 
biological samples in the study clinic. Baseline sampling commenced within the first 
days of the beginning of the spring semester and lasted for one week (i.e. from 
January 31, 2017, to February 5, 2017). During this period, all eligible participants 
who were willing to participate were asked to complete a survey form which 
contained questions about their baseline health conditions, vaccination history and 





Table 2. Survey questions and procedures for different visits. 
 
 
We asked about questions that relate to their baseline social characteristics such as 
alcohol consumption pattern, sleep pattern, and cigarette smoking habits (Appendix 
A). We also assessed their baseline perceived stress and physical activity levels using 
validated questionnaires (55,56) also shown in the Appendix A. Each participant was 
asked to select from a list containing all eligible participants, up to 10 students with 
whom they frequently interact. All the participants were educated about the 
symptoms of ARI and asked to report to the study clinic by text, call or via e-mail as 
soon as they noticed any of the ARI symptoms during the semester. In addition to 
survey sampling, we obtained hair and/or nail specimens, venous blood specimens, 
 Baseline 1 Baseline 2 Case Contact 
Surveys 
Demographic variables + - - - 
Ten frequent contacts + + - - 
Perceived Stress Scale + + + + 
Smoking History + + + + 
Alcohol Intake + + + + 
Sleep Duration + + + + 
aBMI assessment + + - - 
Biologic Samples 
Venous Blood for Serology + + + + 
PAXgene blood + + + + 
Combined Nasal and 
throat swabs 
1 pair 1 pair 2 pairs 2 pairs 
Fomite swab - - + - 
Exhaled breath sample - - + - 
Four frequent contacts - - + + 
Hours spent in room + + - - 
a Body Mass Index; Measurements were only taken in the second baseline if subjects had not participated in the first. 
+ When surveys were conducted 





anterior nasal and oropharyngeal swab specimens from all participants at baseline. 
(See specimen collection protocol below). 
 
Case Evaluation 
We defined as case, any subject whose combined nasal and oropharyngeal swab 
specimens contained a viral ARI pathogen using a qRT-PCR analysis. We classified 
cases as either primary or probable secondary. Primary cases were further classified 
into the self-reported case and surveillance-positive primary cases (Figure 1, Table 
3a).  
Figure 1. Biological samples obtained and the order of their collection in cases and contacts. 
 We defined as a self-reported case, any subject with an illness that constituted any 




We attempted to recruit 4 contacts for each positive primary case. Each recruited contact was evaluated for 7 days 
and the biological samples were obtained from them in the order shown.  
The blue colored boxes indicate negative contacts visit while red indicates a positive contact visit with a matching 
pathogen with that of the primary case. Black colored boxes indicate contacts who were positive for a pathogen 





to the clinic within 48 hours of onset. Surveillance-positive primary cases were those 
who were originally recruited as contacts but whose infector could not be determined 











Primary Cases Cases who can be regarded as the source of infection 
within a *contact network group or cluster. They 
were the first in the cluster to be detected with the 
pathogens of interest in a given 7-day period.  
 Self-reported primary 
 cases 
 
These are the subjects that reported their illness 
directly to the study clinic, whose infections were 
qRT-PCR confirmed and could not be determined to 
be from any other subject in their cluster in the 7days 
before onset. 
 Surveillance-positive 
 primary cases 
Subjects under surveillance who tested positive, 
whose infector could not be determined either 
through epidemiological pathogen matching. 
Probable Secondary Cases 
(for phylogenetic analysis)  
These include: 
i. Self-reported subjects whose infector(s) 
can be inferred to have come from a 
member of a cluster via epidemiological 
pathogen matching  
ii. Surveillance-positive contacts with a 
matching infection with nominating case. 
iii. Surveillance-positive contacts with 
infections that was traced to another 
member of the cohort in the 7 days prior 
to onset. i.e. contacts who had the same 
infection with another participant in the 
same social network group within 7 days 
of illness in the first. 
Surveillance negative contacts Nominated contacts that did not test positive while 
under surveillance.  






Only participants in the main cohort were eligible to be evaluated as self-reported 
cases. Self-reported cases were evaluated on up to 2 consecutive days in the clinic 
depending on the result of the tests carried out on the swab specimens obtained from 
them on the first day of clinic evaluation. Only those whose specimens were positive 
were invited for re-evaluation on the second day of case testing. At each of those 
visits, in addition to updating their social characteristics, we obtained anterior nasal 
and oropharyngeal swab specimens, fomite (cellphone) swab specimens, venous 
blood, and exhaled breath specimens. Nose, oropharyngeal, fomite, and exhaled 
breath specimens facilitate examination of viral shedding and respiratory microbiome 
predictors in models of contagiousness and susceptibility. Self-reported cases were 
asked to identify up to 4 people in the target cohort with whom they interacted in the 
preceding 24 hours. Their swab specimens were immediately processed to identify 
viral pathogens. A follow-up questionnaire was sent to the cases on the 3rd day asking 
them to update their symptoms and to report any new contact they might have 
interacted with in the previous 24 hours. 
Contact surveillance and evaluation 
All the students in the overall eligible group who were selected as close contacts by 
the cases were eligible to be enrolled in the contact arm of the study. To enroll these 
contacts, we sent recruitment e-mails to their university e-mail addresses and handed 
recruitment flyers to the corresponding cases. To be able to describe pre-infectious 
phenotype, it was imperative to identify and enroll exposed contacts before they 
became symptomatic. We hence categorized contact subjects for effective pre-







Table 3b. Describing the Classification of Contacts based on QRT-PCR test result during surveillance 
 
Given the serial interval of about 2.6 days for influenza (31,35), we only enrolled 
contacts who presented to the clinic within 3 days of being named by a case, on the 
premise that they would have already become symptomatic by the 4th day. Enrolled 
contacts were evaluated at the clinic every day for 7 days during which they were 
asked to complete survey questions which asked about their contacts as well as 
questions that relate to their health status (Table 1). We obtained nasal and 
oropharyngeal swabs on all days of clinic visits, but venous blood samples were only 
collected on days 1, 2, 4 and 6 of study clinic visits as shown in Figure 1.  
We alternated the blood collection routine to increases the likelihood of obtaining 
pre-infectious blood samples which we presume to be essential for the identification 
of pre-infectious genetic markers. Their nasal and oropharyngeal swab specimens 
were processed at the laboratory using qPCR and tested for the presence of 44 
infectious agents. Contacts who tested positive during the surveillance period were 
 Notes 
Surveillance positive contacts  
 Positive on the first day of 
 contact visit  
Subjects who were positive on the first day of 
their surveillance 
 Positive on day 2+ Subjects who were negative on the first day of 
their surveillance but later became positive during 
surveillance.  
Surveillance negative contacts  Nominated contacts that did not test positive 





referred to as surveillance positive contacts. If they were tested positive for the same 
ARI virus that the case who nominated them had, then they were referred to as 
probable secondary cases and were evaluated using same procedures as we did the 
self-reported cases while contacts that on the other hand remained negative 
throughout the seven daily visits were referred to as surveillance negative contacts. 
The remaining subject categorization is presented in Table 3a. For the pre-infectious 
analysis, we divided contacts into those who were positive on the first day of 
surveillance, those who were negative on the first day of surveillance but later 
became positive and those who were never positive throughout surveillance (Figure 
3b). 
We sent weekly emails to the target cohort to inquire about illnesses and to encourage 
those who were sick to come to the study clinic for screening and potential evaluation 
as soon as symptoms arise. Undergraduate research assistants were assigned as 
liaisons to each member of the cohort. Liaisons maintained communication with 
study participants throughout the course of the study via the communication medium 
of choice of each participant. Contacts of cases were contacted by email and 
brochures that were given to the cases to distribute (if they agreed), and by liaison 
outreach.  
Specimen Collection Protocol 
We collected different numbers and types of specimens at different clinic 
visits. The number and type of sampling done in the case- and contact-visits are 




January 31, 2017, and February 5, 2017. At the baseline, we obtained a paired nasal 
swab and oropharyngeal swab from the participants. We sampled the anterior part of 
one nostril by rotating the swab applicator 3 times and then placing it inside a vial 
containing 1 mL of universal viral transport medium (UVT) (Becton, Dickson and 
Company, Sparks, Maryland USA). An oropharyngeal swab was obtained by 
sampling the posterior throat and placing the swab into the vial containing the 
anterior nasal swab to make a combined nasal and oropharyngeal specimen. At the 
case and contact evaluation visits, we obtained 2 pairs of nasal and oropharyngeal 
swabs thus producing 2 pairs of combined nasal and oropharyngeal specimens. All 
samplings were done using nylon-tipped flexible plastic-shafted applicators (Becton, 
Dickson and Company, Sparks, Maryland USA). The combined nasal and 
oropharyngeal swabs have been shown to be at least as sensitive as a single 
nasopharyngeal swab (57). 
The specimens were tested using TaqMan® Array Card (TAC; Thermo Fisher 
Scientific, Waltham, MA, USA) which is designed to rapidly detect up to 44 different 
pathogens in a biological specimen. this enabled early confirmation of cases among 
participants, aiding efficient epidemiologic contact investigation and surveillance of 
likely transmission networks between friends and roommates with whom substantial 
contact occurs. 
We collected about 17.5mLs of venous blood from each participant at 
baseline, 15mls of that was collected into a plain blood tube with no anticoagulant 




GmbH, Hombrechtikon, Switzerland). We also collected nail clippings and samples 
of hair strands. Collected blood specimens facilitate investigation of transcriptome 
and immunome signatures, while hair and nail specimens were archived to enable 
subsequent assay for cortisol as a stress biomarker as an additional measure of stress, 
a known marker of infection susceptibility (58). 
A second baseline sampling was done after spring break, between March 27, 
2017, and April 3, 2017, and all the initial baseline procedures were repeated. At each 
case visit, we swabbed the cellphones of the subjects using a swab stick dipped in 
UVT solution. The symptom card presented to the subjects to rate the severity of their 
symptoms at each of the clinic visit is described in the Appendix A. The exhaled 
breath was collected using a Gesundheit-II, as previously described (59), and 
archived for future analysis. 
Data and Statistical Analysis 
All data were cleaned and analyzed using R software. (60). We defined as 
upper respiratory, symptoms of sneezing, sore throat, runny nose, stuffy nose or an 
earache. A lower respiratory symptom was described as any of shortness of breath, 
cough or chest tightness while systemic symptom was any of malaise, headache, 
muscle and joint ache, chills-rigors-fever, nausea, vomiting, diarrhea. We calculated 
scores for each symptom category by summing the scores reported for each symptom 




To identify subjects with more severe illnesses, we defined a term called mild-
to-moderate acute respiratory infections (MMARI) which depends on the PCR cycle 
threshold (CT) value, the subject’s reported symptoms, the measured oral temperature 
at the time of visit and the persistence of the infection in the subject. The Ct value is 
the number of cycles required for the fluorescent signal to cross the threshold (i.e. 
exceeds background level). We defined as an MMARI, any case of a subject who 
fulfills any of the following : (a) tested qPCR positive with a CT value of less than 33 
at least once in a consecutive series of visits regardless of other parameters, (b) tested 
qPCR positive with a CT of 33 or more on detected on at least 2 consecutive days, (c) 
had one of sore throat, cough, stuffy nose, runny nose, shortness of breath, or chest 
tightness in addition to having a CT value of at least 33, (d) whose measured oral 
temperature was at least 38 degrees in addition to having a CT value of at least 40.  
The difference in means of the symptom scores between positive and negative 
self-reported cases was tested using the Student’s t-test. While the difference in the 
proportion of the subjects with MMARI was tested using the Chi-square test. 
Statistical significance was assessed using two-tailed tests with an error level of 0.05. 
The statistical analysis was conducted using the base statistical package of R 
software. The contact network analysis was done using the “igraph” R package (61). 
Network Analysis 
We aggregated all contacts nominated by each subject during the study to 
form a list and then used the list as the subject’s contact network. We analyzed basic 




overall connectivity of the network. The degree is the total number of contacts 
reported by each student during the study while edge density is the ratio of the 
number of links present in the network and the maximum number of links 
possible(62).   
Ethics Statement 
This study was approved by the Institutional Review Boards (IRB) of the 
University of Maryland and the Department of Navy Human Research Protections 
Office. Electronic informed consent was obtained from all participants through an 
electronic signature applied on an online form sent to each participant via e-mail at 
the time of baseline assessment. An in-person informed consent was obtained at the 
time of baseline specimen collection. Repeat in-person consenting was done each 
time a participant was to be enrolled in either the case or contact arm of the study. All 





Chapter 4: Results 
Characteristics of the subjects 
Our study population comprised of college dormitory students; mostly first-year 
students (91.2%); 72% females and aged between 18 to 19 years. The descriptive 
statistics of the demographic, health behavior, health status, and psychosocial 
variables of the study population are shown in Tables 4a and 4b.  
Table 4a. Demographic covariates of viral ARI pathogen detection in all subjects and in contacts. 








Mean age in years ± SD  18.21 ± 0.41 18.07 ± 0.27 18.17 ± 0.38 
Female (%) 49 (72) 11(68.8) 20 (83.3) 
Race (%)    
White 29 (42.6) 8 (50) 12 (50) 
Black/AA 16 (23.5) 2 (12.5) 6 (25) 
Asian Indian 6 (8.8) 1 (6.3) 3 (12.5) 
Chinese 4 (5.8) 1 (6.3) 0 
Filipino 3 (4.4) 2 (12.5) 0 
Korean 3 (4.4) 0 0 
Vietnamese 2 (2.9) 0 1 (4.2) 
Other Asian 4 (5.8) 0 1 (4.2) 
Unknown 1 (1.5) 0 0 
Multi-racial 1 (1.5) 0 1 (4.2) 
Academic Year, N (%)    
First year 62 (91.2)  16 (100) 23 (95.8) 
BMI kg/m2 ± SD 24.54 ± 4.4 22.63 ± 3.3 23.12 ± 3.2 
Smoker, current (%) 4 (5.89) 1 (6.25) 3 (12.5) 
Number of hours spent in 
room 
13.03 ± 2.98 13.72 ± 1.42 12.25 ± 3.55 
Abbreviation: SD, Standard deviation 
 
We compared the study participant characteristics to that of the overall student 




There was a higher proportion of females in our study sample (72%) than in the 
overall student population (46.6%).  However, race and ethnicity proportions in our 
study population (White: 42.6%) were close to those of the overall student population 
(White; 42%).   
Table 4b. Demographic covariates of viral ARI pathogen detection in all subjects and in contacts. 
(Continued) 














49 (80%) 10 (62.5) 20 (83.3) 
Influenza vaccination 
previous season (%) 
34 (55.7%) 10 (62.5) 13 (54.2) 
Influenza vaccination 
current season (%) 
26 (42.3%) 6 (37.5) 9 (37.5) 
Number of 
vaccinations 
2.7 ± 0.7 2.8 ± 0.4 2.6 ± 0.75 
Ever smoked 
cigarette (%) 
3 (4.4) 1 (6.25) 2 (8.3) 
*Perceived Stress 
Score 









Sleep duration – 
hours (Weekdays) 
7.52 ± 1.2 7.73 ± 1.2 7.66 ± 1.4 
Sleep duration - 
hours (Weekends) 
9.14 ± 1.4 9.6 ± 1.3 9.04 ± 1.49 
Alcohol (Drinking 
times per week) 
1.05 ± 1.82 1.87 ± 3.1 0.86 ± 0.92 
Alcohol (Drink 
number per episode) 
2.28 ± 2.44 2.7 ± 2.9 1.96 ± 2.1 
*Perceived Stress Score: Mildly stressed; 0-13, Moderately stressed; 14-27, Severely Stressed; 28-40.  






Study participation and enrollment  
We collected baseline survey data from 75 subjects out of a total of 146 eligible 
participants. Of the 75 subjects, 9.3% (N=7) did not provide any baseline biological 
sample and hence were excluded from all analyses while the remaining 68 from 
whom we obtained complete data were retained in the analyses. 73.5% (N=50) of 
these provided baseline biological samples at the beginning of the semester between 
January 31, 2017, and February 5, 2017, and 88.2% (N=60) provided biological 
samples mid-semester between March 27, 2017, and April 3, 2017, i.e. during the 
second baseline collection period. Only 67.6% (N=46) of all subjects provided 
samples at both baseline sampling period (Figure 2). We screened 59 episodes of self-
reported illnesses reported by 38 subjects some of whom reported more than one 
episode during the study period. As shown in Figure 2, of these 59 illness episodes 24 
(44.4%) were positive for viral ARI pathogens as evaluated by the qRT-PCR test that 
was performed within 24 hours of presentation and was accounted for by 20 of the 38 




Figure 2. Flowchart showing the number of visits to different kinds that occurred 
 
N, unique subjects. n, number of instances of that visit. 
 
Though we attempted to enroll for surveillance, 4 subjects for each of the 59 
confirmed episodes of illness that the cases presented with, we were only able to 
enroll 60 instances in total. Thus, we enrolled 1.1 contacts per case. Figure 3 displays 
the temporal distribution of the positive self-reported cases during the study period 
and when different pathogens were detected.  
There was a midsemester, spring break between March 19 and March 30, hence no 




Figure 3. Temporal distribution of the self-reported cases. 
 
Abbreviation. HPIV: Human Parainfluenza Virus 
Coinfections: 1 subject had 3 viral coinfections, 5 cases were co-infected with 2 pathogens 
 
Pathogens detected 
Figure 4. Viral pathogens detected in the cohort during the semester 
 
 
There were 72 laboratory-confirmed episodes of infections in the cohort. 9 episodes 
of Influenza A (H3N2) illnesses were detected. 15 episodes of Respiratory Syncytial 




in 15 episodes of illness while rhinovirus was only detected in 3 illness episodes.  
Figure 4 shows the number of episodes of various pathogens that were detected. 
Of the 60 contacts surveillances that were carried out, we did not detect any pathogen 
in 26 throughout their surveillance period while there were 34 surveillance positive 
contact visits. Out of those 34 episodes, 13 (38%) were already positive on the first 
day of contact surveillance and 21 were tested positive on subsequent follow-up 
visits. Of the surveillance positive contacts, there were 5 whose pathogens matched 
those of the nominating cases. By this metric, the secondary attack rate was 8.3%. 
Study network and contact surveillances 
Contacts and cases were divided into categories based on the relevance of their 
contribution to transmission network analysis and pre-infectious analyses as 
described in Tables 2a and 2b.  The results of these are summarized in Tables 5a and 
5b.  
Table 5a. Classification of Contacts for Biomarker Analysis. 
 All ARI Influenza A 
Positive on the first day of contact visit 11 (13) * 1 (1) 
Positive on day 2+ 15 (21) 3 (3) 
Surveillance negative 16 36 
* The number in parenthesis is the total number of instances observed while the number outside the parenthesis is 
the number of unique subjects observed 
 
 
Most of the contacts who were not positive on the first day of surveillance tested PCR 
positive on the 3rd day of surveillance (Figure 5). The mean CT value on the first day 




surveillance-positive contacts had sustained-qPCR-detectable (i.e. CT value < 38 
cycles) infection on days 1 and 2 following the first day of detection (Figure 6).  
 
Table 5b. Classification of cases and contacts for transmission analysis. 
 All ARI Influenza A 
Primary cases   
Self-reported cases 46 5 
Surveillance positive primary 16 3 
Probable Secondary Cases 5 1 
Surveillance negative 16 36 
 
Figure 5 Showing the number of contacts who tested positive and when they did during surveillance. 
 





Figure 6. Summary of CT values for the surveillance-positive cases from the first day viral pathogens 
were detected in them. 
 
Abbreviation. CT: Cycle threshold. The Ct value is the number of cycles required for the fluorescent signal to 
cross the threshold (i.e. exceed background level) 
 
Symptom pattern of the study group 
Symptom pattern and in positive self-reported cases is shown in figures 7a, 7b and 
Table 5.  
Figure 7a. Summary of the reported symptom scores of all positive cases on the first day of their clinic 
visits 
 
Upper Respiratory Symptoms: Sneezing, Sore throat, Runny nose, Stuffy nose or an Earache,  
Lower Respiratory Symptoms: Cough, Shortness of breath, Chest tightness  






Figure 7b. Measured oral temperature in the detected ARI cases on the first day of their clinic visit. 
 
Most self-reported cases were only mildly symptomatic. The mean measured oral 
temperature was 37.3’Celcius. The most common symptoms reported in negative 
self-reported cases were; stuffy nose, malaise, and sore throat. The distribution of the 
self-reported symptom scores is summarized in Appendix B. As shown in Table 6a, a 
statistically significant difference was observed in the reported scores for a headache, 
sneezing and runny nose between the positive self-reported cases and the negative 
self-reported cases. Table 6b summarizes the reported symptoms for the contacts who 






Table 6a. Summary of symptom scores for the self-reported cases of ARI. 
 Viral infection 
detected 
N=26 





 Mean Median Mean Median  
Measured Oral 
Temperature 
37.3 37.1 36.8 36.8 0.35 
Upper Respiratory 
Symptoms 
6.3 6 5.03 5 0.03* 
 Runny Nose 1.6 2 1.1 1 0.02* 
 Stuffy Nose 1.6 2 1.4 1 0.33 
 Earache 0.3 0 0.6 0 0.14 
 Sneeze 1 1 0.6 0 0.03* 
 Sore throat 1.8 2 1.4 1.5 0.09 
Lower Respiratory 
Symptoms  
2.3 2 2.15 2 0.65 
 Cough 1.5 2 1.4 2 0.56 
 Shortness of Breath 0.5 0 0.5 0 0.69 
 Chest Tightness 0.3 0 0.3 0 0.94 
Systemic Symptoms  3.3 2 4.5 4 0.17 
 Headache 0.6 0 1.3 1 0.01* 
 Fever, chills 0.8 0 0.6 0 0.4 
 Malaise 1.2 1 1.5 2 0.2 
 Muscle Joint Ache 0.5 0 0.8 0 0.26 
Others      
 Diarrhea 0 0 0.03 0 0.33 
 Nausea 0.2 0 0.3 0 0.44 
 Vomit 0.1 0 0 0 0.16 
MMARI, N (%) 26 (100) -  
* p-value < 0.05 Abbreviation, MMARI, Mild-to-Moderate Acute Respiratory Infection 
 
To qualify as an MMARI, a case must have; (a) been tested qPCR positive with a CT value < 33 at least once 
during the series of consecutive visits regardless of other parameters, (b) been tested qPCR positive on 2 
consecutive days with CT value ≥ 33, (c) had one of sore throat, cough, stuffy nose, runny nose, shortness of 
breath, or chest tightness in addition to having a CT value ≥ 33 during the visit, (d) tested positive with CT value ≥ 






Table 6b. Showing the summary of symptom scores for the contacts tested for ARI 
 Positive on Day 1 
(N=13) 





 Mean Mean Mean 
Measured Oral 
Temperature 
36.87 36.84 36.8 
Upper Respiratory 
Symptoms 
2.39 1.89 1.02 
 Runny Nose 0.46 0.53 0.27 
 Stuffy Nose 0.77 0.47 0.29 
 Earache 0.08 0.12 0.04 
 Sneeze 0.3 0.24 0.18 
 Sore throat 0.77 0.53 0.23 
Lower Respiratory 
Symptoms  
0.92 0.59 0.58 
 Cough 0.85 0.59 0.37 
 Shortness of 
Breath 
0.08 0 0.19 
 Chest 
Tightness 
0 0 0.02 
Systemic 
Symptoms  
1.08 0.54 0.47 
 Headache 0.38 0.18 0.13 
 Fever, chills 0 0 0 
 Malaise 0.38 0.24 0.27 
 Muscle Joint 
Ache 
0.23 0.12 0.04 
Others    
 Diarrhea 0 0 0.03 
 Nausea 0.08 0 0.01 
 Vomit 0 0 0 
MMARI, N (%) 8 (61.5) 4 (19) - 
Abbreviation, MMARI, Mild-to-Moderate Acute Respiratory Infection 
To qualify as an MMARI, a case must have; (a) been tested qPCR positive with a CT value < 33 at least once 
during the series of consecutive visits regardless of other parameters, (b) been tested qPCR positive on 2 
consecutive days with CT value ≥ 33, (c) had one of sore throat, cough, stuffy nose, runny nose, shortness of 
breath, or chest tightness in addition to having a CT value ≥ 33 during the visit or (d) tested positive with CT value 





16 episodes of surveillance positive contacts were identified in the cohort contributed 
by 15 subjects (Tables 2a and 2b). All the surveillance positive contacts reported one 
or more symptoms on the day they tested positive. The mean symptom score was 
higher for upper respiratory, lower respiratory and systemic systems on day 2 
following the detection of the viral pathogen. On the first day of viral pathogen 
detection, only 25% (4 of 16) of the surveillance positive contacts had measured oral 
temperature that was greater than 37.0o Celsius. The mean measured oral temperature 
in the surveillance negative contacts was 36.8o Celsius. Summaries of the symptom 
score and temperature progression before and after qRT-PCR detection of viral 
pathogens in the surveillance positive contacts are shown in Figures 8a and 8b. 
Figure 8a. Symptom progression in the positive contacts before and after qRT-PCR detection of viral 
pathogen. 
 
Upper Respiratory Symptoms: Sneezing, Sore throat, Runny nose, Stuffy nose or an Earache, 
Lower Respiratory Symptoms: Cough, Shortness of breath, Chest tightness 










The link density i.e. the ratio between the total number of connections between the 
subjects and the total number of possible connections is 18.5%. Figure 9a shows the 
basic contact network structure and measurements of the subjects including the mean 
degrees, the density of the network. Figures 9b and 9c illustrate the individuals who 






Figure 9a. Contact network structure of the participating subjects in study cohort based on 24-hour 
contact selection. 
 
The golden circles (nodes) represent the subjects while the black lines represent the links between them. Degree is 
the total number of contacts reported by each student during the study while the edge density is the ratio of the 
number of links present in the network and the maximum number of links possible. 
Average degree: 11.5  





Figure 9b. Contact network structure of the participating subjects showing individuals who tested for 
Influenza A 
 






Chapter 5: Discussion 
Here we have described a college resident community surveillance study where we 
prospectively monitored a select group of students during a semester to identify and 
characterize cases of ARI and their transmissions among their contacts. Using self-
reported contact nomination system, the design of the study provided an opportunity 
to monitor an extended contact network of the subjects with ARI beyond their 
immediate living location (i.e. their rooms). This distinctiveness is an improvement 
over household ARI studies, which are generally limited given that they often fail to 
characterize or identify transmissions that occur outside households. This meant that 
we could potentially account for transmissions that occur in non-household settings 
such as in the library, study rooms, classes, and diners. The prospective nature of the 
study meant that we could obtain serially, biological specimens from ARI cases from 
the day of self-reporting their illness and for 7 days in the exposed contacts till they 
become ill thus providing a great amount of data about the natural course of illness in 
ARI cases and the pre-infectious and convalescent phenotype and genotype in the 
surveillance-positive cases. Other specimens that we obtained: nose, oropharyngeal, 
fomite, and exhaled breath specimens help facilitate examination of viral shedding 
and respiratory microbiome predictors in models of contagiousness and susceptibility. 
Our study eligibility criteria reflected our goal to maximize participation rates. We 
mainly targeted college students in a specific program with an academic focus on 
health on the presumption that they would be more willing to participate than other 
students in non-health-related programs. An additional advantage of enrolling this 




50ft away) to the study clinic and the laboratories of the School of Public Health. The 
study was set out to enroll 4 close contacts for each of the self-reported cases hence 
we restricted the eligible members of our cohort to residents of certain floors in the 
dormitory where most LLC members live (Table 1). We believed 4 contacts were 
reasonably easier for the participants to recall and that number is logistically feasible 
to follow up. Meanwhile, as our target group was a tightly-knit community where 
many of the cases had the same contacts, we could not achieve our goal of enrolling 4 
close contacts per case. 
For the enrolled exposed contacts whom we followed-up for 7 days, we alternated the 
order of venous blood sampling for the following reasons (Figure 1): (1) to increase 
the chances of drawing a day-minus-1 blood specimen (i.e. blood obtained a day 
before qPCR detection of viral particles) and (2) to increase the toleration of blood 
draws among the participants. However, we discovered upon analysis (Figure 5), that 
most of the contacts who became positive, developed illness within the first 5 days of 
surveillance. This suggests that the most important days for evaluating contacts and 
drawing blood specimens are the first 5 days of enrollment and that by alternating 
blood draws we inadvertently obtained a fewer number of day-minus-1 blood 
specimens than the numbers we could have obtained if we had drawn blood daily on 
the first 4 days of surveillance. This observation is in keeping with reports from 
experimental influenza and ARI studies which identified that following inoculation, 
most infected subjects exhibited signs of infection within the first Also, a systematic 
review which examined the serial intervals in 18 influenza household studies, 




We found that most of the enrolled contacts were already positive at the time of 
enrollment implying that most transmissions and onset of disease had occurred in the 
contacts prior to the commencement of the surveillance. Though we encouraged the 
study participants to contact us as soon as they noticed symptoms, it was impossible 
to objectively ascertain the onset of illness in the self-reported cases. Furthermore, in 
the exit survey that was conducted at the study completion, many participants 
reported that they were too busy to report to the clinic when they were sick. We think 
that if we made evaluation less burdensome e.g. by obtaining biological specimens 
from the participants at their convenience in their rooms, we might be able to enroll 
cases and contacts more promptly in the course of their illness and perhaps enroll 
more contacts before they test positive. 
The secondary attack rate of ARI in our target population was 8.3%. Despite our 
conviction that we did not observe some ARI transmissions due to some of the 
reasons mentioned earlier, the attack rate in our study is comparable to what some 
household studies have reported which ranges from 3% to 36% (34). Some studies 
have observed differences in attack rates of ARI in households where the index case 
was a child with some reporting higher attack rates (40,41). Given the relative 
homogeneity of our study population with a mean age of 18.21+/-0.41, it might be 
vital to investigate the transmission dynamics in a different population in the college 
environment. Perhaps, by expanding the study target group to capture the staff and 
faculty that interact with children such as those at the center that provides daycare 
services for pre-school kids as well as the enrolling the kids themselves, we might be 




Most of the qRT-PCR confirmed self-reported cases of ARI observed were only 
mildly symptomatic and so were the surveillance positive contacts. We assume that 
the more serious cases of ARI illnesses present to the University Health Center and/or 
remain confined to their dormitory rooms. Also, most of the surveillance positive 
contacts (75%) were only transiently qRT-PCR positive (i.e. we detected a viral 
pathogen by qPCR assessment once during surveillance but not on subsequent days) 
(Figure 6). While it is generally known that a substantial fraction of cases of ARIs 
and influenza are asymptomatic or associated with mild disease, it might still be 
essential to characterize more severe cases. If transmissibility is related to the severity 
of cases, then results from our study may not be generalizable to more severe cases. 
In a bid to identify the more severe cases of ARI in our cohort, we defined a term – 
MMARI. In future studies, it may be essential to carry out study recruitment exercise 
in the University Health Center in addition to the current design. 
Self-report contact nomination was a very crucial part of our recruitment process for 
this study and its use allowed us to expound the connections within the network group 
in the study cohort. Given that most of the subjects (97%) in our cohort resided in the 
same dormitory, the identified contact network was tightly-knit with an edge density 
of 18.5%. In subsequent studies, when we expand to a larger cohort, we expect to see 
a network structure with well-defined clusters that may provide a suitable structure 
for the assessment of outbreak intervention strategies such as quarantine.  
We collected details about the quality of contacts between subjects such as the 
duration and type of contacts, but those were not included in the network analyses in 




past 24 hours, it may still be subject to recall bias. Hence, in subsequent studies, we 
will incorporate the use of a location-tracking phone application which will help 
identify when 2 or more users are in proximity and will help objectively quantify the 
duration of contacts between subjects enrolled in the study. Also, this may help to 
identify contacts promptly following exposure to an infected case and even allow us 
to identify a much larger number of potential contacts. In addition, it may help us to 
identify and describe the physical characteristics of specific locations where ARI 
transmission occurs. It will also be valuable in the future, to assess the correlation 
between the survey-collected contact nomination data and that collected via location 
tracking software.  
The design and setting of the study meant that there was a need for extensive logistic 
efforts. Student liaisons had to be trained to help with recruitment and to keep 
reminding eligible students to contact the study staff when sick. An exit survey 
conducted towards the end of the study (baseline 2) to quantify unreported illness 
episodes revealed that 59% of those who did not report their illness failed to do so 
because they had forgotten.  Also, the complexity and the large amount of the 
collected data meant that there was a need for extensive data management, cleaning, 
and analytic efforts.  
This current study does not include data about the environmental and physical 
conditions of the student residential building, meanwhile, some studies have 
demonstrated the importance of indoor temperature and humidity in ARI transmission 
in animal models (63,64). Brundage et al showed a significantly higher incidence rate 




ventilation buildings than in their counterparts living in the old barracks during a 47-
month survey period (65).  Other factors such as airflow (the speed of air currents 
flowing through indoor spaces) and ventilation (the degree of mixing between indoor 
and outdoor air) likely play important roles in virus infectivity and transmission of 
ARIs (64). One study showed a correlation between the probability of detecting 
airborne rhinovirus with the carbon dioxide (CO2) content of the air which in turn 
related inversely to ventilation (66). Also, absent in this data are the results from the 
exhaled breath analysis. Another study which underscored the importance of 
examining the exhaled breath following the recovery of infectious influenza virus 
particles from the fine aerosols ≤5 micrometers of some subjects with confirmed 
influenza infections (67).  
In conclusion, in this study, we have shown how ARIs transmission monitoring can 
be achieved in the student living and learning community and how it can provide a 
means of characterizing several relevant covariates. Though the study size was 
relatively small (N=68) we identified some probable secondary transmission. A 
follow-up phylogenetic analysis of the identified pathogens will help confirm 
transmissions. We believe this study design provides a unique opportunity to study 
the relative roles of many important covariates of ARI transmission. Upon expansion 
of the study to a larger cohort, incorporation of environmental monitoring measures 
improved contact network tracking and confirmation of transmission by phylogenetic 
analysis, we believe this design will provide a comprehensive data that will provide 







0 = I have no symptoms, 1 = Just noticeable, 2= Its clearly bothersome from 
time to time, but it doesn’t stop me from participating in activities, 3 = It’s 
quite bothersome most or all of the time, and it stops me from participating in 
activities. 
Runny Nose, Stuffy Nose, Sneezing, Sore Throat, Earache, Muscle (tiredness 
and fatigue), Headache, Muscle and/or joint ache, Sweats, fever, or chills, 
Nausea, Vomiting, Diarrhea, Chest tightness, Shortness of breath, Cough. 
 
International Physical Activity Questionnaire 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling? Think 
about only those physical activities that you did for at least 10 minutes at a 
time. 
2. Again, think only about those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you 
do moderate physical activities like carrying light loads, bicycling at a regular 
pace, or doubles tennis? Do not include walking. 
3. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time? This includes walking at work and at home, walking to travel from 
place to place, and any other walking that you did solely for recreation, sport, 
exercise or leisure. 
4. The last physical activity question is about the time you spent sitting on 
weekdays while at work, at home, while doing course work and during leisure 
time. This includes time spent sitting at a desk, visiting friends, reading 
traveling on a bus or sitting or lying down to watch television. 
5. During the last 7 days, how much time in total did you usually 
spend sitting on a week day? 
 
Sleep and Alcohol History 
1. On how many days in the past week did you drink an alcoholic beverage? 
2. On the days that you drank during the past week, how many drinks did you 
usually have each day? (Count as a drink a can or bottle of beer; a wine 
cooler, a glass of wine, a shot of liquor or a mixed drink or cocktail.) 
3. On a typical weekday, how many hours per day do you spend sleeping? 
Include day and night. 
4. On a typical weekend day, how many hours per day do you spend sleeping? 
Include day and night. Consider a typical week at school. 
 
Perceived Stress Scale 




1. In the last month, how often have you been upset because of something that 
happened unexpectedly?  
2. In the last month, how often have you felt that you were unable to control the 
important things in your life? 
3. In the last month, how often have you felt nervous and “stressed”?  
4. In the last month, how often have you felt confident about your ability to 
handle your personal problems?  
5. In the last month, how often have you felt that things were going your way? 
6. In the last month, how often have you found that you could not cope with all 
the things that you had to do?  
7. In the last month, how often have you been able to control irritations in your 
life?  
8. In the last month, how often have you felt that you were on top of things?  
9. In the last month, how often have you been angered because of things that 
were outside of your control?  
10.  In the last month, how often have you felt difficulties were piling up so high 
that you could not overcome them? 
  
 
Appendix B: Showing the distribution of the self-reported symptom severity scores 
(normalized) in all cases. 
 
Normalization: The sum for each category was divided by the highest possible score then multiplied by 15 so the resulting 




  Appendix C. Showing the reported types of contact that occurred between subjects and the 
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